Sympathetic Mapping/ Ablation of Renal Nerves Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 220 participants.

Also called NCT02761811

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 220 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02761811
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02761811. Randomized; single masking; primary purpose treatment. Start 2016-06-30 (registry gives no type); primary completion 2022-08-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sympathetic Mapping/ Ablation of Renal Nerves Trial
Acronym
SMART
Condition
Hypertension
Intervention (Device)
SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator
Lead sponsor
SyMap Medical (Suzhou), Ltd. (class: industry)
Collaborator
Tigermed Consulting Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct02761811
Content hash
10a10ff99d1573c34870e342986725acdcfbe3f3ba557a26a212a6e13fa68cc8